C50.619
Malignant neoplasm of axillary tail of unspecified female breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the axillary tail of the female breast, classified under ICD-10 code C50.619, refers to a type of breast cancer that originates in the axillary tail—a part of the breast tissue that extends toward the armpit. This condition is characterized by the uncontrolled growth of abnormal cells within the breast tissue and can spread to neighboring tissues or distant parts of the body if not diagnosed and treated promptly. Recognizing the specific location and nature of this cancer helps guide appropriate management and treatment strategies.
Causes & Symptoms
Clinical Causes: Genetic factors: inheritance of gene mutations such as BRCA1 or BRCA2 Hormonal influences: prolonged exposure to estrogen and progesterone Environmental exposures: radiation or carcinogenic substances Lifestyle factors: high alcohol consumption, sedentary lifestyle, obesity Previous breast conditions: history of benign breast disease or prior breast cancer Age: increased risk with advancing age, typically postmenopausal women
Key Symptoms: Lump or mass in the axillary (armpit) region or upper outer breast Changes in the size, shape, or appearance of the breast Skin changes over the breast, such as dimpling or puckering Nipple alterations, including inversion or discharge Persistent pain in the breast or armpit that does not resolve Swelling or thickening in the breast tissue
Diagnostic & Treatment
Diagnosis Path: Medical history review and physical examination focusing on breast and axillary region Imaging studies such as mammography and ultrasound to identify and assess the extent of the tumor Biopsy procedures (core needle or surgical biopsy) to obtain tissue samples for histopathological analysis MRI scans may be utilized for detailed imaging and assessment of tumor spread Lymph node evaluation through fine needle aspiration or biopsy, as metastasis commonly occurs in the regional lymph nodes
Treatment Protocols: Surgical options: lumpectomy (breast-conserving surgery) or mastectomy, often with axillary lymph node dissection or sentinel lymph node biopsy Radiation therapy: to destroy residual cancer cells post-surgery and reduce recurrence risk Chemotherapy: systemic treatment to target cancer cells throughout the body, especially in cases with lymph node involvement or higher stage Hormone therapy: for hormone receptor-positive cancers, drugs like tamoxifen or aromatase inhibitors may be prescribed Targeted therapy: agents designed to interfere with specific molecular targets in cancer cells Follow-up care: regular monitoring through imaging, physical exams, and laboratory tests to detect any recurrence or new cancers
Clinical Advice & FAQs
Billing Guidance
Is C50.619 a billable ICD-10 code?
Yes, C50.619 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.619?
Clinical documentation must specify the nature of Malignant neoplasm of axillary tail of unspecified female breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference